Dr. Barry Dworkin

The official website

  • Home
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology

New therapeutic agent entering Phase 1 trials that has been reported to block a protein (common in many cancers) responsible for tumour growth. Best to wait for results before assigning the “holy grail” designation noted in some reports.

August 8, 2023September 14, 2023Dr. Barry Dworkin

Medical Mythbusting Commentary for August 8, 2023

[display_podcast]

Source:
Cancer-killing pill that annihilates tumours hailed as ‘holy grail’ breakthrough

Reference:
Small molecule targeting of transcription-replication conflict for selective chemotherapy

Related posts:

  1. Genes research offers cancer treatment hope
  2. Chip technology may help monitor cancer treatment success
  3. Fluorescent nanoparticles pop their corks to kill cancer cells.
  4. Saccharin seems to block cancer cell functions and may allow chemo and radiotherapy to work with greater efficacy
  • AOH1996
  • cancer

Post navigation

Sunday House Call, #888, August 6, 2023: When belief and reality clash.
Canada will likely see rise in COVID cases by late August: infectious disease expert.
Login

Copyright © 2023 Dr. Barry Dworkin.